Tag: Rodapitant (Varubi)

By Posted on Posted in New Drug Approval, Thasso Post, Theragenomic Medicine Tagged with , , ,

September 2, 2015 – The U.S. Food and Drug Administration approved Rodapitant (Varubi) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Rodapitant (Varubi) is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated …

Rodapitant (Varubi) approved as a new treatment for nausea and vomiting under chemotherapy Read more »

By Posted on Posted in New Drug Approval, Thasso Post, Theragenomic Medicine Tagged with , , ,

2. September 2015 – Die Amerikanische Food and Drug Administration (FDA) hat eben Rodapitant (Varubi) zugelassen. Rodapitant (Varubi)um soll Chemotherapie-induzierte Übelkeit und Erbrechen (Emesis) verhindern. Rodapitant (Varubi) wird bei Erwachsenen in Kombination mit anderen Arzneimitteln (Brechreizhemmenden Agentien) eingesetzt um die Übelkeit …

Rodapitant (Varubi) als neue Behandlung für Übelkeit und Erbrechen nach Chemotherapie zugelassen Read more »